Included on this page is clinical trial information and other test information. Please click on the link to learn more details about the trial, its purpose, who may participate, locations, and phone numbers for more information. Please seek advice from your medical teams about the clinical trials or studies you are intrested in. The items are listed in date order & updated periodically:
A Study to Assess AK002 in Eosinophilic Gastritis and/or Eosinophilic Duodenitis (Formerly Referred to as Eosinophilic Gastroenteritis) (ENIGMA 2)
Ages: 18-80
Study type: Interventional
Sponsor: Allakos
How to Participate: NCT04322604
Locations: Multiple locations in the U.S.
Contact: 833.209.8331
A Study of Lirentelimab (AK002) in Patients with Active Eosinophilic Esophagitis (KRYPTOS)
Ages: 12-80
Study type: Interventional
Sponsor: Allakos
How to Participate: NCT04322708
Locations: Multiple locations in the U.S.
Contact: 833.209.8331
Eosinophilic Gastritis Study for children, teens, and adults 12 to 60 years old.
How to participate: Benralizumab Eosinphilic Gastritis Study brochure_Final
Cininnati Children’s Hospital Medical Center
Contact: Marc Rothenberg, MD, PhD 513-803-0257
Cristin Murray-Petzold 513-803-9079
How to participate: NCT03633617
Regeneron Pharmaceuticals
| Study Start Date:August 2018 |
| Contact: Clinical Trials Administrator | 844-734-6643 | clinicaltrials@regeneron.com |
Benralizumab for Eosinophilic Gastritis (ANTI-IL5RA)
Study Start Date: March 30, 2018
Cincinnati Children’s Hospital
How to Participate: NCT03473977
Study Coordinator: Tal Cohen
Phone: 513-517-1074
Email: Tal.cohen@cchmc.org
Effect of Elemental Diet on Adult Patients with Eosinophilic Gastroenteritis (ELEMENT)
How to Participate: You must contact the study coordinator directly:
Northwestern University, Chicago
Study Coordinator: Angelika Zalewski, BS
Phone: 312-695-4054
Email: angelika.zalewski@northwestern.edu
Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE) (FLUTE)
| Study Start Date: | June 2017 |
Adare Pharmaceuticals, Inc.
How to Participate: NCT03191864
| Study Start Date: | January 2016 |
Children’s Hospital Medical Center, Cincinnati
How to Participate: NCT02610816
Cytosponge and Dietary Therapy in EoE
| Study Start Date: | November 2015 |
Mayo Clinic
How to Participate: NCT02599558
| Study Start Date: | November 2015 |
Shire
How to Participate: NCT02605837
Milk Patch for Eosinophilic Esophagitis (SMILEE)
| Study Start Date: | October 2015 |
Children’s Hospital of Philadelphia
How to Participate: NCT02579876
OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages
| Study Start Date: | June 2015 |
National Institute of Allergy and Infectious Diseases (NIAID)
How to Participate: NTC02523118
Oral Cromolyn Sodium for the Treatment of Eosinophilic Esophagitis
| Study Start Date: | February 2015 |
University of Tennessee
How to Participate: NTC02371941
Study of Dupilumab in Adult Patients With Active Eosinophilic Esophagitis (EoE)
| Study Start Date: | February 2015 |
Regeneron Pharmaceuticals
How to Participate: NTC02379052
Food Antigen in Eosinophilic Esophagitis (EoE)
| Study Start Date: | April 2015 |
Mayo Clinic
How to Participate: NCT02434705
The Effect of Sucralfate Slurry in Patients With Eosinophilic Esophagitis (EoE)
| Study Start Date: | January 2015 |
Mayo Clinic
How to Participate: NCT02353078
EndoFLIP Use in Upper GI Tract Stenosis
| Study Start Date: | December 2014 |
University of Pennsylvania
How to Participate: NCT02354716
| Study Start Date: | November 2014 |
Mayo Clinic
How to Participate: NCT023144554
Fibrostenotic Eosinophilic Esophagitis: Assessment Tools
| Study Start Date: | September 2014 |
University of Colorado, Denver
How to Participate: NCT02453126
Value of Patch Testing in Direct Diet Therapy for Eosinophilic Esophagitis (EoE)
| Study Start Date: | August 2014 |
Mayo Clinic
How to Participate: NCT02227836
| Study Start Date: | November 2015 |
Shire
How to Participate: NCT02605837
Budesonide Effervescent Tablet vs. Placebo in Active Eosinophilic Esophagitis (EOS-1)
| Study Start Date: | April 2015 |
Dr. Falk Pharma GmbH
How to Participate: NCT02434029
Esophageal String Test in Eosinophilic Esophagitis
| Study Start Date: | December 2013 |
University of Colorado, Denver
How to Participate: NTC02008903
Mucosal Impedance and Eosinophilic Esophagitis (EoE)
| Study Start Date: | September 2013 |
Mayo Clinic
How to Participate: NTC01953575
Budesonide Versus Fluticasone for Treatment of Eosinophilic Esophagitis
| Study Start Date: | December 2013 |
University of North Carolina, Chapel Hill
How to Participate: NTC02019758
Nasal Nitric Oxide Levels in EoE
| Study Start Date: | August 2013 |
Mayo Clinic
How to Participate: NCT01929824
Testing Effectiveness of Losartan in Patients With EoE With or Without a CTD
| Study Start Date: | January 2013 |
Children’s Hospital Medical Center, Cincinnati
How to Participate: NCT01808196
Molecular Basis of Food Allergy
| Study Start Date: | April 2013 |
Children’s Hospital of Philadelphia
How to Participate: NTC01832324
Cytosponge Protocol IRB 11-006429
| Study Start Date: | April 2012 |
University of Cambridge
How to Participate: NTC01585103
Eosinophilic Esophagitis Databank (CoFAR5)
| Study Start Date: | March 2011 |
Children’s Hospital Medical Center, Cincinnati
How to Participate: NTC01323803
| Study Start Date: | July 2009 |
University Hospital Inselspital, Berne
How to Participate: NTC00939263
Data and Sample Collection Study to Elucidate the Mechanisms of Eosinophilic Disorders
| Study Start Date: | December 2005 |
Children’s Hospital Medical Center, Cincinnati
How to Participate: NTC00267501